Skip to main content
OpenTrials
Completed

NCT Number: NCT01999959

Effect of Pertubation on Pregnancy Rates Before Intrauterine Insemination Treatment

To demonstrate a possible beneficial impact of pertubation we designed a randomized prospective study, in which uterine washing was administered prior to insemination in patients diagnosed with unexplained infertility.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–44 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2

Primary location

Gazi University Hospital

Ankara, Cankaya, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age of 18-44 years; presence of regular menstrual cycles and ovulation; absence of tubal occlusion on HSG; sperm concentration >15 million spermatozoa/ml and total sperm number >39 million/ml according to WHO criteria

Exclusion criteria

  • the presence of endocrinologic disease; use of nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids; clinical findings suggestive of pelvic inflammatory disease; and the presence of undiagnosed uterine bleeding

Treatment and study plan

Pertubation

Procedure

a lavage procedure of the intrauterine cavity and bilateral fallopian tubes

Primary outcomes

  1. Pregnancy rate

    Time frame: 6 months

    Pregnancy rate at 6 month-follow-up

Sponsors and collaborators

Lead sponsor

Gazi University

Other

Registry information

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Dec 3, 2013
Registry last updated
Dec 3, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.